A new trial-design emphasis is emerging from community clinicians, who say many patients never reach novel therapies because trial protocols are optimized for academic referral pathways. The reporting highlights that community physicians often face structural barriers—staffing, visit cadence, and resource requirements—that can make standard trial designs impractical. The article describes a model in which practicing clinicians help write protocols, adjusting trial design to fit community workflows and reduce friction for referral and participation. The approach centers on protocol feasibility as a determinant of access. For developers and sponsors, the implication is that recruitment strategies increasingly need to be built into trial design, not treated as an afterthought.
Get the Daily Brief